Kerr Claire, McDowell Brona, Cosgrove Aidan, Walsh Deirdre, Bradbury Ian, McDonough Suzanne
Gait Analysis Laboratory, UK.
Dev Med Child Neurol. 2006 Nov;48(11):870-6. doi: 10.1017/S0012162206001915.
A randomized placebo-controlled trial was carried out to investigate the efficacy of neuromuscular electrical stimulation (NMES) and threshold electrical stimulation (TES) in strengthening the quadriceps muscles of both legs in children with cerebral palsy (CP). Sixty children (38 males, 22 females; mean age 11y [SD 3y 6mo]; age range 5-16y) were randomized to one of the following groups: NMES (n=18), TES (n=20), or placebo (n=22). Clinical presentations were diplegia (n=55), quadriplegia (n=1), dystonia (n=1), ataxia (n=1), and non-classifiable CP (n=2). Thirty-four children walked unaided, 17 used posterior walkers, six used crutches, and the remaining three used sticks for mobility. Peak torque of the left and right quadriceps muscles, gross motor function, and impact of disability were assessed at baseline and end of treatment (16wks), and at a 6-week follow-up visit. No statistically significant difference was demonstrated between NMES or TES versus placebo for strength or function. Statistically significant differences were observed between NMES and TES versus placebo for impact of disability at the end of treatment, but only between TES and placebo at the 6-week follow-up. In conclusion, further evidence is required to show whether NMES and/or TES may be useful as an adjunct to therapy in ambulatory children with diplegia who find resistive strengthening programmes difficult.
开展了一项随机安慰剂对照试验,以研究神经肌肉电刺激(NMES)和阈电刺激(TES)对增强脑瘫(CP)患儿双腿股四头肌的疗效。60名儿童(38名男性,22名女性;平均年龄11岁[标准差3岁6个月];年龄范围5 - 16岁)被随机分为以下几组:NMES组(n = 18)、TES组(n = 20)或安慰剂组(n = 22)。临床表现为双瘫(n = 55)、四肢瘫(n = 1)、肌张力障碍(n = 1)、共济失调(n = 1)和不可分类的CP(n = 2)。34名儿童无需辅助行走,17名使用后助行器,6名使用拐杖,其余3名使用手杖辅助行动。在基线、治疗结束时(16周)以及6周随访时评估左右股四头肌的峰值扭矩、粗大运动功能和残疾影响。在力量或功能方面,NMES或TES与安慰剂之间未显示出统计学上的显著差异。在治疗结束时,NMES和TES与安慰剂相比,在残疾影响方面观察到统计学上的显著差异,但在6周随访时仅TES与安慰剂之间存在差异。总之,对于难以进行抗阻强化训练的双瘫门诊患儿,是否可以将NMES和/或TES作为治疗辅助手段,还需要进一步的证据。